NG2/MCSP Antibody (LHM-2) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2585B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Immunohistochemistry, Western Blot
Label
Biotin
Antibody Source
Monoclonal Mouse IgG1 Clone # LHM-2
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human melanoma cells
Specificity
Detects human NG2/MCSP in Western blots.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for NG2/MCSP Antibody (LHM-2) [Biotin]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: NG2/MCSP
Long Name
Chondroitin Sulfate Proteoglycan NG2/Melanoma Associated Chondroitin Sulfate Proteoglycan
Alternate Names
AN2, CSPG4, HMW-MAA, MCSP, MCSPG, MEL-CSPG
Gene Symbol
CSPG4
Additional NG2/MCSP Products
Product Documents for NG2/MCSP Antibody (LHM-2) [Biotin]
Product Specific Notices for NG2/MCSP Antibody (LHM-2) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...